Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib

Hepatocellular carcinoma (HCC) is the third-leading cause of cancer-related death with limited treatment options and frequent resistance to sorafenib, the only drug currently approved for first-line therapy. Therefore, better understanding of HCC tumor biology and its resistance to treatment is urge...

Descripción completa

Detalles Bibliográficos
Autores principales: Quintavalle, Cristina, Hindupur, Sravanth Kumar, Quagliata, Luca, Pallante, Pierlorenzo, Nigro, Cecilia, Condorelli, Gerolama, Andersen, Jesper Bøje, Tagscherer, Katrin Elisabeth, Roth, Wilfried, Beguinot, Francesco, Heim, Markus Hermann, Ng, Charlotte Kiu Yan, Piscuoglio, Salvatore, Matter, Matthias Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682677/
https://www.ncbi.nlm.nih.gov/pubmed/29072691
http://dx.doi.org/10.1038/cddis.2017.512

Ejemplares similares

Ejemplares similares